Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
As part of the deal, AstraZeneca is acquiring the exclusive rights to ECC5004, an investigational oral once-daily pill for treating obesity, type 2 diabetes and other cardiometabolic conditions
This can be useful, but it also means you might not be eating enough food to get all the nutrients your body needs
This causes harmful buildup, slows cell growth, triggers inflammation, and leads to chronic diseases
Medications are prescribed based on a thorough medical evaluation and are dispensed through licensed retail pharmacies or manufacturer-direct programs
For systemic effect, we recommend using either PCCA Base A or PCCA MBK
US$ 28.40
US$ 29.46
US$ 24.10
US$ 21.00
US$ 20.40
US$ 29.17
US$ 29.16
US$ 21.86
US$ 23.96
US$ 28.91
